Search Results

There are 30528 results for: content related to: Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study)

  1. Glucagon-like peptide analogues for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Deepson S. Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh and Ailsa Snaith

    Published Online : 5 OCT 2011, DOI: 10.1002/14651858.CD006423.pub2

  2. An overview of once-weekly glucagon-like peptide-1 receptor agonists—available efficacy and safety data and perspectives for the future

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 5, May 2011, Pages: 394–407, S. Madsbad, U. Kielgast, M. Asmar, C. F. Deacon, S. S. Torekov and J. J. Holst

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1463-1326.2011.01357.x

  3. Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 3, March 2013, Pages: 234–240, R. E. Pratley, D. Urosevic, M. Boldrin, R. Balena and for the T-emerge 6 Study Group

    Version of Record online : 30 SEP 2012, DOI: 10.1111/dom.12009

  4. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 10, October 2014, Pages: 900–909, Y. G. Kim, S. Hahn, T. J. Oh, K. S. Park and Y. M. Cho

    Version of Record online : 15 APR 2014, DOI: 10.1111/dom.12293

  5. You have free access to this content
    Is insulin the preferred treatment for HbA1c >9%?

    Journal of Diabetes

    Volume 9, Issue 9, September 2017, Pages: 814–816, Zachary Bloomgarden

    Version of Record online : 28 JUN 2017, DOI: 10.1111/1753-0407.12575

  6. You have full text access to this OnlineOpen article
    Is insulin the most effective injectable antihyperglycaemic therapy?

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 2, February 2015, Pages: 145–151, J. B. Buse, A. Peters, D. Russell-Jones, S. Furber, M. Donsmark, J. Han, L. MacConell, D. Maggs and M. Diamant

    Version of Record online : 9 NOV 2014, DOI: 10.1111/dom.12402

  7. Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 8, August 2011, Pages: 703–710, K. Y. Thong, B. Jose, N. Sukumar, M. L. Cull, A. P. Mills, T. Sathyapalan, W. Shafiq, A. S. Rigby, C. Walton, R. E. J. Ryder and on behalf of the ABCD nationwide exenatide audit contributors

    Version of Record online : 21 JUN 2011, DOI: 10.1111/j.1463-1326.2011.01393.x

  8. You have full text access to this OnlineOpen article
    Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin

    Journal of Diabetes Investigation

    Volume 5, Issue 1, January 2014, Pages: 51–59, Hye Soo Chung, Sunghwan Suh, Mi Yeon Kim, Soo Kyoung Kim, Hee Kyung Kim, Ji In Lee, Kyu Yeon Hur, Jae Hyeon Kim, Yong-ki Min, Myung-shik Lee, Kwang-Won Kim, Sun Wook Kim, Jae Hoon Chung and Moon-Kyu Lee

    Version of Record online : 2 SEP 2013, DOI: 10.1111/jdi.12127

  9. Posters

    Diabetic Medicine

    Volume 23, Issue s4, December 2006, Pages: 265–410,

    Version of Record online : 7 NOV 2006, DOI: 10.1111/j.1464-5491.2006.02037_13.x

  10. You have full text access to this OnlineOpen article
    Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany

    Diabetes, Obesity and Metabolism

    Kamlesh Khunti, Thomas R. Godec, Jesús Medina, Laura Garcia-Alvarez, Josh Hiller, Marilia B. Gomes, Javier Cid-Ruzafa, Bernard Charbonnel, Peter Fenici, Niklas Hammar, Kiyoshi Hashigami, Mikhail Kosiborod, Antonio Nicolucci, Marina V. Shestakova, Linong Ji and Stuart Pocock

    Version of Record online : 28 SEP 2017, DOI: 10.1111/dom.13083

  11. You have full text access to this OnlineOpen article
    Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 2, February 2015, Pages: 136–144, S. A. Ross, A. E. Caballero, S. Del Prato, B. Gallwitz, D. Lewis-D'Agostino, Z. Bailes, S. Thiemann, S. Patel, H.-J. Woerle and M. von Eynatten

    Version of Record online : 19 NOV 2014, DOI: 10.1111/dom.12399

  12. A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 3, March 2013, Pages: 213–223, D. A. Scott, K. S. Boye, L. Timlin, J. F. Clark and J. H. Best

    Version of Record online : 3 OCT 2012, DOI: 10.1111/dom.12007

  13. You have full text access to this OnlineOpen article
    Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c

    Diabetes, Obesity and Metabolism

    Baptist Gallwitz, Samuel Dagogo-Jack, Vivian Thieu, Luis-Emilio Garcia-Perez, Imre Pavo, Maria Yu, Kenneth E. Robertson, Nan Zhang and Francesco Giorgino

    Version of Record online : 5 OCT 2017, DOI: 10.1111/dom.13086

  14. Clinical care and other categories posters: Audit

    Diabetic Medicine

    Volume 26, Issue s1, March 2009, Pages: 79–199,

    Version of Record online : 4 MAR 2009, DOI: 10.1111/j.1464-5491.2009.02663.x

  15. Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy

    Journal of Diabetes

    Volume 9, Issue 3, March 2017, Pages: 248–255, Jun-Sing Wang, I-Te Lee, Wen-Jane Lee, Shi-Dou Lin, Shih-Li Su, Shih-Te Tu, Yao-Hsien Tseng, Shih-Yi Lin and Wayne Huey-Herng Sheu

    Version of Record online : 31 MAY 2016, DOI: 10.1111/1753-0407.12406

  16. Pharmacological management of type 2 diabetes: the potential of incretin-based therapies

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 2, February 2011, Pages: 99–117, B. Charbonnel and B. Cariou

    Version of Record online : 27 DEC 2010, DOI: 10.1111/j.1463-1326.2010.01317.x

  17. Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 8, August 2012, Pages: 737–744, C. Pan, X. Xing, P. Han, S. Zheng, J. Ma, J. Liu, X. Lv, J. Lu, G. Bader and on behalf of all investigators

    Version of Record online : 1 APR 2012, DOI: 10.1111/j.1463-1326.2012.01593.x

  18. You have free access to this content
    Clinical care and other categories posters

    Diabetic Medicine

    Volume 32, Issue S1, March 2015, Pages: 100–206,

    Version of Record online : 11 MAR 2015, DOI: 10.1111/dme.12668_1

  19. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 2, February 2009, Pages: 167–176, R. E. Pratley, M. S. Kipnes, P. R. Fleck, C. Wilson, Q. Mekki and Alogliptin Study 007 Group

    Version of Record online : 29 DEC 2008, DOI: 10.1111/j.1463-1326.2008.01016.x

  20. You have full text access to this Open Access content
    Predictor variables and an equation for estimating HbA1c attainable by initiation of basal supported oral therapy

    Journal of Diabetes Investigation

    Volume 3, Issue 2, April 2012, Pages: 164–169, Naotaka Fujita, Satoru Tsujii, Hirohito Kuwata, Rie Kurokawa, Satoshi Matsunaga, Shintaro Okamura, Tsuyoshi Mashitani, Miyuki Furuya, Masako Kitatani and Hitoshi Ishii

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.2040-1124.2011.00164.x